AI Insight
This review examines how to improve clinical trial design for older patients, who constitute the fastest growing demographic in healthcare but remain underrepresented in research. The authors identify three critical domains for advancement: ensuring representative patient selection and inclusion, choosing appropriate therapeutic interventions, and measuring outcomes relevant to older populations. Recent literature has proposed numerous strategies to address these gaps and enhance trial relevance for elderly patients.
Why it matters
Current clinical trials often lack adequate representation of older patients, leading to treatment guidelines based on evidence from younger populations that may not apply to elderly patients with different physiological profiles and healthcare needs. Implementing these recommendations could improve clinical decision-making and health outcomes for the rapidly expanding aging population.
Understand the Science
Older patients represent the fastest growing patient group in clinical care. They are a heterogeneous group, for whom evidence for making treatment decisions is often scarce. Important domains for advancing the relevance of clinical trials for older patients are selection and inclusion of representative patients, choosing appropriate therapeutic interventions, and studying relevant outcomes. In the last decade, a myriad of publications has recommended multiple solutions that improve the relevance of trials for older people.
Source: [Review] Advancing the relevance of clinical trials for older patients